NAIFA - Overview: Antinuclear Antibodies, HEp-2 Substrate, IgG, Serum
Evaluation of patients suspected of having systemic autoimmune rheumatic disease (ANA-associated rheumatic diseases or connective tissue disease) or organ-specific autoimmune diseases such as autoimmune liver diseases
VASC - Overview: Antineutrophil Cytoplasmic Antibodies Vasculitis Panel, Serum
Evaluating patients with clinical features of anti-neutrophil cytoplasmic antibody-associated vasculitis, specifically granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis
APGH - Overview: Alpha-Subunit Pituitary Tumor Marker, Serum
Adjunct in the diagnosis of pituitary tumors As part of the follow-up of treated pituitary tumor patients Differential diagnosis of thyrotropin-secreting pituitary tumor versus thyroid hormone resistance Differential diagnosis of...
MASF - Overview: Angiosarcoma, MYC (8q24) Amplification, FISH, Tissue
Identifying MYC amplification to aid in the differentiation of cutaneous angiosarcomas from atypical vascular lesions after radiotherapy
AATTF - Overview: Antithrombin Activity, with Reflex to Antithrombin Antigen, Plasma
Diagnosis of antithrombin deficiency, acquired or congenital
ASUCR - Overview: Arsenic/Creatinine, Ratio, with Reflex, Random, Urine
Preferred screening test for detection of arsenic exposure using random urine specimens
CTNBT - Overview: B-Catenin Mutation Analysis, Next-Generation Sequencing, Tumor
Distinguishing desmoid-type fibromatosis from other soft tissue tumors by assessing gene targets within the beta-catenin (CTNNB1) gene
WBGDD - Overview: Beta-Globin Gene Cluster, Deletion/Duplication, Varies
Determining the etiology of hereditary persistence of fetal hemoglobin (HPFH), delta-beta thalassemia, or other large deletions involving the beta-globin gene cluster Diagnosing less common causes of beta thalassemia; these large...
CHRHB - Overview: Chromosome Analysis, Hematologic Disorders, Blood
Assisting in the classification and follow-up of certain malignant hematological disorders when bone marrow is not available This test is not useful for congenital disorders.
Evaluating for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and related demyelinating peripheral neuropathies
inflammatory-bowel-disease-diagnostic-testing-algorithm.pdf
YES <50 mcg/g <50 mcg/g Abnormal >50 mcg/g Normal ANCA present ASCA IgG and IgA absent ANCA absent ASCA IgG or IgA present ANCA absent ASCA IgG or IgA absent >120 mcg/g50-120 mcg/g NO Assessing a patient...
Algorithms - Mayo Clinic Laboratories
B C D E F G H I J K L M
united-states-shipping-guide.pdf
U N ITED STATES SH IPPIN G G U ID E TRANSPORTING SPECIMENS WITHIN THE UNITED STATES 2 | UNITED STATES SHIPPING GUIDE UNITED STATES SHIPPING GUIDE | 2 TABLE OF CONTENTS STEP ONE | DANGEROUS...
U N ITED STATES C O U RIER SH IPPIN G G U ID E TRANSPORTING SPECIMENS WITHIN THE UNITED STATES 2 | UNITED STATES SHIPPING GUIDE THIS GUIDE HAS BEEN DEVELOPED TO MEET THE FOLLOWING OBJECTIVES: •...
Test Catalog - Mayo Clinic Laboratories
B C D E F G H I J K L